Don’t forget that Medigap policies also do not include Part D, so you will purchase your drug plan separately.
Bolte Insurance Agency’s Post
More Relevant Posts
-
Capstone’s Hunter Hammond and Angela Lamari's analysis was featured in Politico Pro on the potential impact of IRA price negotiations on drug manufacturers and PBMs. They noted that while manufacturers could offer rebates for better formulary positions, there’s a limit to discounts for profitability. Explore their insights in the full article: https://lnkd.in/gWFGkqXE Learn more about our healthcare expertise here: https://lnkd.in/gscwed4X and reach us at corporateadvisory@capstonedc.com #IRANegotiations #DrugPricing #Healthcare #Medicare
To view or add a comment, sign in
-
Challenging FDA-approved drug dangers! Every year, 110,000 lives are lost to FDA-approved drugs, while vital health information is blocked. Hear more from Jonathan Emord and Rob Verkerk, interviewed by Mike Adams, on the economic and health implications of FDA censorship. Join our movement for truth—sign the #FreeSpeech4Health petition to fight for open information 👉 https://bit.ly/3Q47wtr #FDAReform #HealthFreedom #FreeSpeech4Health
Jonathan Emord and Rob Verkerk interviewed by Mike Adams on the Economic and Health Implications of FDA Censorship.
To view or add a comment, sign in
-
Recent #FTC report on #PBM's business #practices and the subsequent legal action that FTC plans to take will be interesting to observe, considering the impications for all U.S #healthcare stakeholders. The U.S #political #landscape following the November elections may further shape these issues. FTC's report slammed the PBM industry for manipulating the drug #supplychain to profit at the expense of #patients and independent #pharmacists; while the PBMs have historically pointed the finger at #drugmakers which set list prices for the #medications. https://lnkd.in/ebKyCdJt #drugprice #listprice #marketaccess https://lnkd.in/eQiAcdSA
FTC to sue three largest PBMs over drug price practices: WSJ
biopharmadive.com
To view or add a comment, sign in
-
Employers, it's not just price-gouging for insulin, it's for most of the newer medications. Please rethink how you are purchasing your pharmacy benefits! First, most of you are using one of the big box brokers, that do a good job for many other aspects. However, for pharmacy benefits, they are locked into the payoffs from the big PBMs. Then they use the "Rebate" tool to lure you into the big PBM world. This is a No-Win World!!! Please realize that rebates are a based on a percentage of the cost of the medications, the higher the cost of the medications the higher the rebates!!!! As well, this is YOUR money that you spent on the high-cost medications in which you are receiving only a percentage of the rebates!!! Now look at your last 3 years of Skyrizi utilization, I am sure it has gone sky high. Why was Humira or now the biosimilars not good enough now? It's all about the money $$$$!!! Enough is enough, please hire a nonconflicted pharmacy consultant that will work in you best interest versus your current big box broker that is a paid agent for your PBM, to help you resolve this enormous and tragic issue that is harming many of your employees and their families!!! Contact me if you would like a list of nonconflicted pharmacy consultants that can help you reduce your liability for class action lawsuits (in which the officers of your company are personally responsible) and Dept. of Labor sanctions from the CAA regulations. As well, if you are locked into a contract with a big PBM, contact me about our "Fiduciary" independent utilization management services that will contractually ensure your members receive the right medications and not just the most profitable medications for your PBM. #CEO #COO #CFO #CHRO #Fidcuciary #CAA #DoTheRightThing
The biggest reason U.S. drug prices far exceed international peers: our addiction to ‘discounts’ “For PBMs paid based on discounts negotiated, a high retail price with big discounts is better than a low retail price with no discounts.”
Employers take fights with Big Pharma and PBMs over insulin price-gouging charges to one federal court
benefitspro.com
To view or add a comment, sign in
-
At Clarity Labs, we understand the crucial role of drug testing in preventing overdoses. By detecting the presence of substances early, our tests can alert individuals and healthcare providers to potential risks, enabling timely intervention and support. 🤝 Drug testing isn't just about compliance—it's a lifesaving measure that helps maintain safety and health. Stay safe, and stay tested with Clarity Labs. #PreventOverdoses #DrugSafety #ClarityLabs
To view or add a comment, sign in
-
At Clarity Labs, we understand the crucial role of drug testing in preventing overdoses. By detecting the presence of substances early, our tests can alert individuals and healthcare providers to potential risks, enabling timely intervention and support. 🤝 Drug testing isn't just about compliance—it's a lifesaving measure that helps maintain safety and health. Stay safe, and stay tested with Clarity Labs. #PreventOverdoses #DrugSafety #ClarityLabs
To view or add a comment, sign in
-
Speaking of the #MedicareAnniversary and #MedicarePartD… Consumers who are shopping for a Part D drug plan should consider several things beyond costs. NCOA’s printable, shareable checklist encourages them to look at plans' formularies, networks, convenience, and more to aid their decision-making. ✅👇 https://lnkd.in/eRMMrSqa
Use This Checklist to Help You Choose A Medicare Part D Plan
ncoa.org
To view or add a comment, sign in
-
Shareable Insights by Citeline | Week 2/2025 Source: Pink Sheet 𝗥𝘅 𝗘𝗻𝗳𝗼𝗿𝗰𝗲𝗺𝗲𝗻𝘁 𝗜𝗻 𝟮𝟬𝟮𝟱: 𝗦𝗵𝗶𝗳𝘁 𝗔𝘄𝗮𝘆 𝗙𝗿𝗼𝗺 𝗢𝗽𝗶𝗼𝗶𝗱 𝗠𝗮𝗸𝗲𝗿𝘀 𝗕𝘂𝘁 𝗧𝗼𝘂𝗴𝗵𝗲𝗿 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗢𝗻 𝗔𝗱/𝗣𝗿𝗼𝗺𝗼 ◾ 𝗪𝗵𝗼 𝘀𝗵𝗼𝘂𝗹𝗱 𝗿𝗲𝗮𝗱 𝘁𝗵𝗶𝘀? Compliance execs at firms that market Rx products in the US. ◾ 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗶𝘁? US FDA enforcement priorities in the coming year. ◾ 𝗪𝗵𝘆 𝗱𝗼𝗲𝘀 𝗶𝘁 𝗺𝗮𝘁𝘁𝗲𝗿? •The promotional pressures you, and your competitors, will be facing could be shifting. https://lnkd.in/dtSkkE3M
Rx Enforcement In 2025: Shift Away From Opioid Makers But Tougher Approach On Ad/Promo
insights.citeline.com
To view or add a comment, sign in
-
#opcsolidarity #Colorado No one has to die from an #overdose. We have a healthcare solution. And it's time to use it! #OPCsarehealth #OPCsaresafety #OPCsarelove #welovepeoplewhousedrugs No more #overdoseawareness We demand #overdosepreventionaction #OPCNationalSolidarityWeek Drug Policy Alliance bit.ly/OPC_SolidarityWeek
To view or add a comment, sign in
-
Implementing the PharmChek® Sweat Patch in your recovery program will significantly reduce the administrative burden of managing random testing schedules. Message me to learn about streamlining your monitoring protocols. #PharmChek #DrugTesting #YouOnlySweatTheTruth
💡 Can a simple patch revolutionize accountability in recovery courts? In a system where trust and accuracy are so crucial, conventional drug testing methods often fall short by relying on: ❌ Sporadic testing schedules ❌ Single-point-in-time results ❌ Vulnerable methods prone to tampering These are only a few challenges that can undermine accountability—and participants' progress. So, what if there were a better way? Continuous monitoring with the PharmChek® Sweat Patch changes the game: 🔷 24/7 monitoring means no gaps in accountability. 🔷 Its tamper-evident design ensures the integrity of results. 🔷 Results are court-admissible, providing reliable evidence for legal proceedings. This isn’t just about tracking substance use—it’s about creating an environment of trust and fairness that supports recovery. 💡 Recovery courts using tools like the Sweat Patch are seeing: 🔷 Improved compliance rates 🔷 More informed decision-making by court professionals 🔷 Better outcomes for participants Click below👇🏼to learn how continuous monitoring with PharmChek® is transforming recovery programs. https://lnkd.in/gj97JCPV #PharmChek #DrugTesting #YouOnlySweatTheTruth
To view or add a comment, sign in